Biotech · Private company · Plainsboro, NJ, US

Atux Iskay Group LLC

Track this companyFree. Adds Atux Iskay Group LLC to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards3

Direct protein phosphatase 2A (PP2A) activators as novel Alzheimer’s Disease (AD) therapeuticsFiscal year 2025 · $828.6KNIH RePORTER 5R44AG071040-03 · fetched Nov 12, 2026
Direct protein phosphatase 2A (PP2A) activators as novel Alzheimer’s Disease (AD) therapeuticsFiscal year 2024 · $1.7MNIH RePORTER 2R44AG071040-02 · fetched Nov 12, 2026
SBIR CONCEPT AWARD - THERAPEUTICS - SULFONYL-UREA AND SULFONAMIDE PP2A ACTIVATORS AS MYCN AMPLIFIED NEUROBLASTOMA (NBL) THERAPEUTICSFiscal year 2024 · $355KNIH RePORTER 75N91024C00009-0-9999-1 · fetched Nov 12, 2026